Early Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of STR-P005

NCT07655453 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed/Refractory Autoimmune Diseases

Interventions

DRUG: STR-P005

Sponsor

Starna Therapeutics